Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Center of Molecular Research (CMR), also known as Isotope CMR, is a leading Russian-based company specializing in the production and global supply of stable isotopes and radiopharmaceuticals. Founded in 1993, the company has established itself as one of the world's largest manufacturers of Oxygen-18 water, a critical precursor for Fluorine-18 used in Positron Emission Tomography (PET) imaging. CMR's extensive product portfolio includes a wide range of radionuclides, precursors, reagents, and cold kits for nuclear medicine, as well as specialized equipment for radiopharmacy. The company provides diagnostic and therapeutic tracers targeting specific biomarkers such as PSMA for prostate cancer and somatostatin receptors for neuroendocrine tumors. Operating in compliance with GMP standards, CMR serves a diverse clientele including research institutes, medical facilities, and industrial partners across more than 30 countries. The company also acts as a key distributor for major international radiopharmaceutical firms in the Russian market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Isotope CMR.